List all topics under these competencies
MI 4.1-4.9 MI 5.1-5.5 MI 6.1-6.3 MI 7.1-7.5 MI 8.1-8.4 microbiology competency topics medical curriculum
https://www.microrao.com/microbiology_competencies_objective…
NMC CBME microbiology competency MI 4.1 to MI 8.4 complete list gastrointestinal hepatobiliary genitourinary India MBBS
https://easynotes4all.com/wp-content/uploads/2026/04/Microbi…
https://bldedu.ac.in/wp-content/uploads/2025/05/MBBS-Phase-I…
| Code | Topic |
|---|---|
| MI 4.1 | Define and differentiate between diarrhea, dysentery and food poisoning. Enumerate the microbial agents causing them. |
| MI 4.2 | Describe the etiopathogenesis, clinical course and laboratory diagnosis of common diarrheal diseases - E. coli, Salmonella, Shigella, V. cholerae, Campylobacter, viral gastroenteritis, Giardia, Coccidian parasites |
| MI 4.3 | Describe the etiopathogenesis, clinical features and laboratory diagnosis of enteric fever (Salmonella typhi/paratyphi) |
| MI 4.4 | Describe the procedure for collection, transport and processing of stool specimens; interpret stool examination results |
| MI 4.5 | Describe the etiopathogenesis, clinical course and laboratory diagnosis of hepatic infections - liver abscess (amoebic & pyogenic), hydatid disease |
| MI 4.6 | Describe the etiopathogenesis, clinical features and laboratory diagnosis of food poisoning (Staphylococcus aureus, Clostridium perfringens, Bacillus cereus) |
| MI 4.7 | Describe the etiopathogenesis, clinical features, laboratory diagnosis and prophylaxis of enterically transmitted viral hepatitis (Hepatitis A & E) |
| MI 4.8 | Describe the etiopathogenesis, clinical features, laboratory diagnosis and prophylaxis of parenterally transmitted viral hepatitis (Hepatitis B, C & D); discuss viral markers |
| MI 4.9 | Suggest the most appropriate laboratory test based on clinical presentation in a suspected viral hepatitis case; interpret viral hepatitis markers and serology reports |
| Code | Topic |
|---|---|
| MI 5.1 | Enumerate microbial agents causing anaerobic infections. Describe the pathogenesis, clinical course and laboratory diagnosis of anaerobic infections (Clostridium perfringens, C. tetani, C. botulinum, non-sporing anaerobes - gas gangrene, tetanus, botulism) |
| MI 5.2 | Explain the etiopathogenesis, clinical course and laboratory diagnosis of bone & joint infections caused by bacterial, fungal, viral and parasitic agents (osteomyelitis, septic arthritis) |
| MI 5.3 | Explain the etiopathogenesis, clinical course and laboratory diagnosis of skin and soft tissue infections caused by bacterial (S. aureus, S. pyogenes, Anthrax), fungal (dermatophytes, subcutaneous mycoses), viral (poxvirus) and parasitic agents |
| MI 5.4 | Differentiate between infective and non-infective lesions in the skin. Enlist microbes causing systemic disease with involvement of skin |
| MI 5.5 | Describe the etiopathogenesis, clinical course, complications and laboratory diagnosis of mycobacterial infections involving skin & soft tissue - leprosy (Mycobacterium leprae), with emphasis on specimen collection |
| Code | Topic |
|---|---|
| MI 6.1 | Enumerate microbial agents causing meningitis. Explain the pathogenesis, clinical course and laboratory diagnosis of meningitis caused by bacterial, fungal, viral and parasitic agents (N. meningitidis, S. pneumoniae, H. influenzae, Cryptococcus, viral meningitis) |
| MI 6.2 | Describe the etiopathogenesis, clinical course and laboratory diagnosis of encephalitis and other CNS infections - viral (rabies, slow viral diseases, herpes encephalitis), parasitic (toxoplasmosis, neurocysticercosis, free-living amoeba), prions |
| MI 6.3 | Demonstrate the appropriate collection and transport of CSF; interpret CSF findings (microscopy, culture, biochemistry) in different types of meningitis/encephalitis |
| Code | Topic |
|---|---|
| MI 7.1 | Enumerate microbial agents causing upper respiratory tract infections (URTI). Describe the etiopathogenesis and laboratory diagnosis - Corynebacterium diphtheriae (diphtheria), Streptococcus pyogenes, influenza virus, parainfluenza, RSV, mumps, coronavirus |
| MI 7.2 | Enumerate microbial agents causing lower respiratory tract infections (LRTI). Describe the etiopathogenesis and laboratory diagnosis - Mycobacterium tuberculosis (TB), non-tuberculous mycobacteria, Streptococcus pneumoniae, Klebsiella, Legionella, Adenovirus, Aspergillus, Pneumocystis jirovecii |
| MI 7.3 | Describe the etiopathogenesis, clinical course and laboratory diagnosis of Mycobacterium tuberculosis infection including drug resistance patterns; discuss BCG vaccination |
| MI 7.4 | Demonstrate collection and transport of throat swab; identify agents from Albert's stain and Gram stain of throat swab and correlate with clinical findings |
| MI 7.5 | Identify common etiologic agents of lower respiratory tract infections from Gram-stained and Acid-fast stained smear of sputum/BAL/tracheal aspirate and correlate with clinical findings |
| Code | Topic |
|---|---|
| MI 8.1 | Describe the etiopathogenesis and laboratory diagnosis of common bacterial, viral, fungal and parasitic infections of the genitourinary system - UTI pathogens (E. coli, Proteus, Klebsiella, Candida albicans), urethritis, pyelonephritis |
| MI 8.2 | Enlist common sexually transmitted infections (STIs). Explain the pathogenesis, laboratory diagnosis and prevention of common bacterial and viral STIs - Neisseria gonorrhoeae (gonorrhea), Treponema pallidum (syphilis), Chlamydia trachomatis, Haemophilus ducreyi (soft chancre), LGV, Donovanosis, genital herpes, genital warts (HPV), bacterial vaginosis, vulvovaginitis (Trichomonas, Candida), non-gonococcal urethritis |
| MI 8.3 | Describe the role of oncogenic viruses in the evolution of virus-associated malignancy - HPV (cervical cancer), EBV (Burkitt's lymphoma), Hepatitis B/C (liver cancer); discuss mechanisms and preventive strategies (vaccination, screening) |
| MI 8.4 | Describe the etiologic agents of emerging infectious diseases; discuss the clinical course and diagnosis - SARS-CoV, MERS-CoV, Ebola, Zika, Nipah virus; epidemiology, outbreak response |